Form 4: Alphatec CEO Awarded Over 1.2M Performance RSUs

Alphatec Holdings, Inc. CEO Patrick Miles received significant performance-based Restricted Stock Unit awards, aligning executive incentives with long-term shareholder value.

Summary

• CEO Patrick Miles was awarded a total of 1,271,999 Restricted Stock Units (RSUs) on February 25, 2026.
• This includes 611,673 performance-based RSUs from a January 29, 2025 award, vesting in three equal installments on March 5, 2026, March 5, 2027, and March 5, 2028, upon confirmation of 2025 performance criteria satisfaction.
• An additional 305,707 RSUs were awarded, vesting in three equal installments on March 5, 2027, March 5, 2028, and March 5, 2029.
• 48,913 RSUs were granted in lieu of a portion of the 2025 cash bonus, with vesting scheduled for December 4, 2026.
• Two separate performance-based RSU awards of up to 152,853 each were granted, tied to achieving specific 30-day average common stock trading prices of $25.00 by December 31, 2028, and $36.00 by December 31, 2030, or meeting certain operational metrics.
• Beneficial ownership also reflects the forfeiture of 103,391 previously reported RSUs due to unmet performance criteria.
• Following these transactions, the CEO directly beneficially owns 5,998,300 shares of common stock and indirectly owns 10,900 shares via an IRA and 250,000 shares via MOM, LLC.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting strong alignment between executive compensation and long-term shareholder value through significant performance-based RSU awards, despite a prior forfeiture.

Positives

• Significant RSU awards totaling 1,271,999 units demonstrate continued commitment and incentive alignment for the CEO.
• A substantial portion of the awards are performance-based, directly linking executive compensation to company stock price appreciation (targets of $25.00 and $36.00) and operational metrics.
• The grant of 48,913 RSUs in lieu of a cash bonus indicates a preference for equity-based compensation, aligning management's interests with long-term shareholder value.

Negatives

• Forfeiture of 103,391 previously reported RSUs indicates that certain performance criteria were not met, highlighting the challenging nature of some targets.

Risks

• Failure to achieve specific stock price targets ($25.00 by December 31, 2028, and $36.00 by December 31, 2030) or operational metrics could result in non-vesting of performance-based RSUs.

Future Outlook

The filing indicates a long-term incentive structure for the CEO, with significant RSU awards vesting over several years through March 2029. A substantial portion of these awards are performance-based, tied to achieving specific stock price targets of $25.00 by December 31, 2028, and $36.00 by December 31, 2030, or meeting certain operational metrics. This aligns the CEO's future compensation with the company's long-term growth and shareholder value creation.

Industry Context

StockSavvy.ai notes that the use of performance-based Restricted Stock Units (RSUs) with multi-year vesting schedules and specific stock price targets is a common practice in the medical device and biotechnology sectors. This approach aims to align executive incentives with long-term shareholder value creation and strategic growth objectives, particularly in industries requiring significant R&D investment and market penetration. The targets of $25.00 and $36.00 per share suggest management's confidence in substantial future stock appreciation.

Comparison to Industry Standards

• The structure of performance-based RSUs with stock price and operational metric hurdles is consistent with best practices in executive compensation across the healthcare technology industry, similar to companies like Stryker (SYK) or Zimmer Biomet (ZBH) which often tie executive incentives to revenue growth, EPS, or stock performance.
• The forfeiture of 103,391 RSUs due to unmet performance criteria demonstrates that the compensation committee's targets are rigorous and not merely symbolic, reflecting a commitment to pay-for-performance principles.
• The grant of RSUs in lieu of a cash bonus is a strong signal of management's belief in the company's future equity value, a practice often seen in high-growth companies where executives prefer long-term equity upside over immediate cash.

Corporate Governance

Stakeholder Impact

• Shareholders: The significant performance-based RSU awards align the CEO's financial interests with long-term shareholder value creation, potentially leading to increased motivation for stock price appreciation and operational excellence. The forfeiture of previous RSUs for unmet targets reinforces a pay-for-performance culture.
• Employees: While not directly impacting all employees, the executive compensation structure sets a precedent for performance-driven incentives within the company.

Next Steps

• Vesting of 611,673 RSUs in three equal installments on March 5, 2026, March 5, 2027, and March 5, 2028.
• Vesting of 305,707 RSUs in three equal installments on March 5, 2027, March 5, 2028, and March 5, 2029.
• Vesting of 48,913 RSUs on December 4, 2026.
• Achievement of a 30-day average trading price of at least $25.00 per share by December 31, 2028, for certain performance-based RSUs.
• Achievement of a 30-day average trading price of at least $36.00 per share by December 31, 2030, for certain performance-based RSUs.
• Achievement of certain operational metrics by December 31, 2028, and December 31, 2030, for performance-based RSUs.

Key Dates

Recommendation

The filing details executive compensation, specifically RSU awards and a forfeiture, which are generally expected events within a company's compensation structure. While the performance-based awards signal management's confidence and align interests with shareholders, the prior forfeiture indicates that targets are challenging. This information alone does not provide a strong catalyst for a 'buy' or 'sell' recommendation but rather reinforces a 'hold' position for investors awaiting broader financial results and strategic updates.

Keywords

Alphatec Holdings, ATEC, Patrick Miles, Restricted Stock Units, RSU, Executive Compensation, Performance-Based Awards, Insider Trading, SEC Form 4, Stock Awards, Corporate Governance